PennyStockPayCheck.com Rss

Featured Posts

Chase Bank Limits Cash Withdrawals, Bans International... Before you read this report, remember to sign up to http://pennystockpaycheck.com for 100% free stock alerts Chase Bank has moved to limit cash withdrawals while banning business customers from sending...

Read more

Richemont chairman Johann Rupert to take 'grey gap... Billionaire 62-year-old to take 12 months off from Cartier and Montblanc luxury goods groupRichemont's chairman and founder Johann Rupert is to take a year off from September, leaving management of the...

Read more

Cambodia: aftermath of fatal shoe factory collapse... Workers clear rubble following the collapse of a shoe factory in Kampong Speu, Cambodia, on Thursday

Read more

Spate of recent shock departures by 50-something CEOs While the rising financial rewards of running a modern multinational have been well publicised, executive recruiters say the pressures of the job have also been ratcheted upOn approaching his 60th birthday...

Read more

UK Uncut loses legal challenge over Goldman Sachs tax... While judge agreed the deal was 'not a glorious episode in the history of the Revenue', he ruled it was not unlawfulCampaign group UK Uncut Legal Action has lost its high court challenge over the legality...

Read more

Randgold Resources Limited: Notification of major interest in shares

Category : World News

JERSEY, CHANNEL ISLANDS–(Marketwired – Apr 22, 2013) – Randgold Resources Limited (NASDAQ: GOLD) (LSE: RRS)

Link: Randgold Resources Limited: Notification of major interest in shares

Post to Twitter

Diamyd Medical AB (DMYDY: OTCQX International) | Information relating to the Extraordinary General Meeting of Diamyd Medical on April 22 regarding the proposed restructuring of the Diamyd Group

Category : World News

Provided that the Extraordinary General Meeting of Diamyd Medical AB to be held on April 22 resolves in favor of the proposed restructuring of the Diamyd Group, after which Diamyd Medical AB will be renamed Mertiva AB, the incoming Board of Directors in the future Mertiva AB plans to appoint Andreas Bergsten as the President at a statutory meeting following the General Meeting. The proposed restructuring entails, among other effects, that the subsidiary Diamyd Therapeutics AB will be distributed to shareholders and the intention is to list the company on NASDAQ OMX First North. The current President of Diamyd Medical AB, Peter Zerhouni, will remain as President of Diamyd Therapeutics AB.

Background to the restructuring
As previously announced in press releases issued on February 18 and March 21, 2013, the summons to an Extraordinary General Meeting was brought about due to an agreement reached by a group of shareholders in Diamyd Medical AB who together represent a majority of the votes and share capital in the company. The agreement entails, among other factors, that the shares in the subsidiary Diamyd Therapeutics AB, which will be capitalized at approximately SEK 50 million and own the existing diabetes operations and the holding in Periphagen, Inc., will be distributed to shareholders. The company will be renamed Diamyd Medical AB. At the same time, the Parent Company will be renamed Mertiva AB. Liquid assets of more than SEK 300 million and the holdings in Protein Sciences Corporation and Mercodia AB will remain in Mertiva AB. The greater part of the liquid assets in Mertiva AB is proposed to be distributed to the shareholders as soon as possible.


Change of President in Diamyd Medical (future Mertiva)

The incoming Board of Directors of the future Mertiva AB plans to appoint Andreas Bergsten as President in a statutory Board meeting following the Extraordinary General Meeting to be held on April 22.
Andreas Bergsten, born in 1967, is currently working as a consultant in the fields of finance and company management and, in his capacity as a consultant, has worked primarily for venture capital firms. In the past, Andreas has served as CFO of four different companies and, prior to this, he was employed at Citigroup, initially as a financial analyst and subsequently as a key account manager. Andreas holds a Master of Science in Business and Economics from the Stockholm School of Economics and the McGill University MBA Program.
The incoming Board of Directors of the future Mertiva AB intends to bring up the issue of moving the company’s listing from NASDAQ OMX Nordic Stockholm to another, unregulated marketplace.


Redemption procedure in Diamyd Medical (future Mertiva) and distribution in kind of Diamyd Therapeutics

As previously announced, the distribution of liquid assets in the future Mertiva AB is proposed to take place by distributing non-restricted equity through voluntary redemption of shares. Shareholders will receive one redemption right per share held and five redemption rights entitle the shareholder to request redemption of one share in the company. For each share redeemed, the shareholder will receive cash payment of SEK 20. The Board of Directors also proposes that the General Meeting approve a dividend in the form of all shares in the wholly owned subsidiary Diamyd Therapeutics AB, whereby three Series A shares in the future Mertiva AB will carry entitlement to one Series A share in the subsidiary and three Series B shares in the future Mertiva AB will carry entitlement to one Series B share in the subsidiary.

Summary of timetable for the redemption procedure and distribution in kind of Diamyd Therapeutics

April 22, 2013
Extraordinary General Meeting in Diamyd Medical. Final day for trading in the Diamyd share, including redemption rights and entitlement to distribution in kind

April 23, 2013

First day of trading in the Diamyd share, excluding redemption rights and entitlement to distribution in kind

April 25, 2013
Record date for receiving redemption rights and entitlement to distribution in kind

April 30 – May 21, 2013
Period of registration to request redemption

April 30 – May 16, 2013

Trading in redemption rights on NASDAQ OMX Stockholm

Around June 14, 2013
Payment of redemption proceeds


Listing of Diamyd Therapeutics (future Diamyd Medical) on NASDAQ OMX First North

As announced earlier, the intention is to make the shares in Diamyd Therapeutics AB available for trading on NASDAQ OMX First North. The first day of trading is expected to be in mid-May 2013. Diamyd Therapeutics AB will be renamed Diamyd Medical AB at the same time as the current Diamyd Medical AB will be renamed Mertiva AB.

Peter Zerhouni, the current President of Diamyd Medical AB (future Mertiva AB) will remain in his position as President of Diamyd Therapeutics AB (future Diamyd Medical AB).

The Board of Directors of Diamyd Therapeutics AB (future Diamyd Medical AB) will initially comprise Anders Essen-M

Post to Twitter

Bonuses cut at Nasdaq following Facebook debacle

Category : Business

Nasdaq is giving chief executive Robert Greifeld a smaller bonus this year, a decision the company says is directly linked to the bungled Facebook IPO.

Read this article: Bonuses cut at Nasdaq following Facebook debacle

Post to Twitter

Dow and S&P 500 close at new record highs

Category : Business, Stocks

Stocks surge on China trade figures and Fed minutes. Nasdaq leads rally.

Read more: Dow and S&P 500 close at new record highs

Post to Twitter

NUS Deploys the Largest Education Wireless Environment in Singapore and Southeast Asia

Category : Stocks

SINGAPORE–(Marketwired – Apr 9, 2013) – Cisco (NASDAQ: CSCO)

See the original post here: NUS Deploys the Largest Education Wireless Environment in Singapore and Southeast Asia

Post to Twitter

Notice of AGM

Category : Stocks, World News

JERSEY, CHANNEL ISLANDS–(Marketwire – Mar 26, 2013) – RANDGOLD RESOURCES LIMITED (NASDAQ: GOLD)
(LSE: RRS)

Read the original: Notice of AGM

Post to Twitter

Lucara Recovers 239 Carat Diamond

Category : World News

VANCOUVER, BRITISH COLUMBIA–(Marketwire – March 18, 2013) - Lucara Diamond Corp. (TSX:LUC)(BOTSWANA:LUC)(NASDAQ OMX First North:LUC) is very pleased to announce the recovery of a 239.2 carat diamond from its Karowe Mine in Botswana. In addition to the recovery of this exceptional gem, two more large stones weighing 124.0 carats and 71.1 carats have also been recovered.

Continue reading here: Lucara Recovers 239 Carat Diamond

Post to Twitter

Sycamore Networks, Inc. (SCMR: OTC Link) | Venue Change

Category : Stocks, World News

Fri, Mar 08, 2013 12:00 – Sycamore Networks, Inc. (SCMR: OTC Link) – Venue Change – The symbol, SCMR, no longer trades on Nasdaq. As of Fri, Mar 08, 2013, SCMR trades on OTC Link. You may find a complete list of venue changes at otcmarkets.com.

Follow this link: Sycamore Networks, Inc. (SCMR: OTC Link) | Venue Change

Post to Twitter

4 questions for Nasdaq’s private share market

Category : Business, Stocks

NASDAQ is putting its imprimatur on private shares trading, but several questions remain.

Link: 4 questions for Nasdaq’s private share market

Post to Twitter

INVESTOR ALERT: Former Louisiana Attorney General and Kahn Swick & Foti, LLC, Remind Investors With Large Financial Interests of Lead Plaintiff Deadline in Class Action Lawsuit Against Affymax, Inc. – AFFY

Category : Stocks

NEW ORLEANS, LA–(Marketwire – Feb 28, 2013) – Kahn Swick & Foti, LLC (“KSF”) and KSF partner, the former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until April 29, 2013 to file lead plaintiff applications in a securities class action lawsuit against Affymax, Inc. (NASDAQ: AFFY), if they purchased the Company’s common stock during the period between December 8, 2011 and February 22, 2013, inclusive (the “Class Period”). This action is pending in the United States District Court for the Northern District of California.

Read the original here: INVESTOR ALERT: Former Louisiana Attorney General and Kahn Swick & Foti, LLC, Remind Investors With Large Financial Interests of Lead Plaintiff Deadline in Class Action Lawsuit Against Affymax, Inc. – AFFY

Post to Twitter